The company entered the OTC business in 2007 and it has grown to have established brands such as Manforce, HealthOK, Prega ...

This realignment is part of a broader strategy to enhance focus on the consumer business, which currently contributes 7% to ...

In an official statement, the CCI said the proposed transaction involves the acquisition of 100% per cent shareholding of ...

The Competition Commission of India has approved Mankind Pharma's ₹13,630 crore acquisition of Bharat Serums and Vaccines.

The CCI has cleared Mankind Pharma's proposed acquisition of 100% stake in Bharat Serums and Vaccines for ₹13,630 crore.

Mankind Pharma's Q1 profit surged 10% YoY to ₹543 crore; brokerage Motilal Oswal expects 14% earnings CAGR over FY24-26 ...

Mankind Pharma Ltd. receives regulatory approvals for 100% acquisition of Bharat Serums and Vaccines Ltd. worth ₹13,630 crore ...

Deal involves Mankind buying 100 per cent equity in Bharat Serums from PE firm Advent International at an enterprise value of ...

Mankind Pharma’s consumer products portfolio includes several trusted brands Manforce, HealthOK, Prega News, AcneStar, ...

Mankind Pharma Limited announced today its plans to raise up to ₹100,000 crore through the issuance of non-convertible ...

Mankind Pharma has been in focus since the company announced the acquisition of Bharat Serums and Vaccines from Advent ...

Mankind Pharma will issue non-convertible debentures (NCDs) and commercial papers (CP) worth ₹5,000 crore. These funds will ...